Interactions of formulation excipients with proteins in solution and in the dried state.
about
Quantifying the molecular origins of opposite solvent effects on protein-protein interactionsDevelopment of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine FormulationBiophysical evaluation of aminoclay as an effective protectant for protein stabilization during freeze-drying and storageQuantitative characterization of local protein solvation to predict solvent effects on protein structure.Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.Preferential Interactions and the Effect of Protein PEGylation.Nanostructured thin film polymer devices for constant-rate protein deliveryIdentification of Protein-Excipient Interaction Hotspots Using Computational Approaches.Effects of Water on Structure and Dynamics of Trehalose Glasses at Low Water Contents and its Relationship to Preservation Outcomes.Protein refolding using chemical refolding additives.Production of prone-to-aggregate proteins.Solid-state protein formulations.Liquid formulations for long-term storage of monoclonal IgGs.A multiscale view of therapeutic protein aggregation: a colloid science perspective.Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.Development of a candidate stabilizing formulation for bulk storage of a double mutant heat labile toxin (dmLT) protein based adjuvant.Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.Low-volume solubility assessment during high-concentration protein formulation development.Glycerol inhibits the primary pathways and transforms the secondary pathway of insulin aggregation.A systematic approach toward stabilization of CagL, a protein antigen from Helicobacter pylori that is a candidate subunit vaccineAdsorption behavior of a human monoclonal antibody at hydrophilic and hydrophobic surfaces.One-step synthesis of protein-encapsulated microspheres in a porous scaffold by freeze-drying double emulsions and tuneable protein release.Liquid formulations for stabilizing IgMs during physical stress and long-term storage.Factors affecting the physical stability (aggregation) of peptide therapeutics.The effect of amorphous calcium phosphate on protein protection against thermal denaturation.Effect of molecular weight and ratio of poly ethylene glycols' derivatives in combination with trehalose on stability of freeze-dried IgG.Tension-Activated Delivery of Small Molecules and Proteins from Superhydrophobic Composites.Effects of Drying Process on an IgG1 Monoclonal Antibody Using Solid-State Hydrogen Deuterium Exchange with Mass Spectrometric Analysis (ssHDX-MS).Stabilization of RDT target antigens present in dried Plasmodium falciparum-infected samples for validating malaria rapid diagnostic tests at the point of care.Studies towards the stabilisation of a mushroom phytase produced by submerged cultivation.Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.Long-term stability of influenza vaccine in a dissolving microneedle patch.Antibody adsorption on the surface of water studied by neutron reflection.Revealing interaction between sulfobutylether-β-cyclodextrin and reserpine by chemiluminescence and site-directed molecular docking.Impact of microbial growth inhibition and proteolytic activity on the stability of a new formulation containing a phytate-degrading enzyme obtained from mushroom.Interaction between the photosensitizer lumichrome and human serum albumin: effect of excipients.Development of a simple assay system for protein-stabilizing efficiency based on hemoglobin protection against denaturation and measurement of the cooperative effect of mixing protein stabilizers.Stabilization studies on bacterially produced human paraoxonase 1 for improving its shelf life.Stabilization of dry protein coatings with compatible solutesThe influence of pH, polyethylene glycol and polyacrylic acid on the stability of stem bromelain
P2860
Q27324515-CB90ED47-5569-43CE-82F7-9669801A04D3Q28553530-ED298D16-12DC-489B-B290-894CD82E1A7EQ30396724-1E6A33BE-4EBA-4FF6-A8C7-A3D380E2C32DQ30421481-B43C1C1C-DC6D-41C2-97CF-0AB235E535C4Q33649828-9FFD9B48-A444-4AF8-AD29-B0607714B647Q35730064-1F640A5A-CBCE-4D59-8288-45404840A082Q36344850-BCDB874E-06BD-4DC9-AD6F-23AE771A7E93Q37050590-DCB9578D-C56D-4F6B-B866-25CBFC8CF27CQ37076547-26D0B727-9208-4F60-87F4-B0FC5E62AD70Q38042408-83D66B6B-9AE6-4BC9-B3AF-03E05D5FC068Q38161235-E8DE0351-4642-4FB5-9CCD-F345C560B327Q38309879-7EC17CA0-76C5-40E6-A961-7725090EC4CBQ38318567-360F20A3-A1A4-45F0-B9A9-D6AD4716F9FDQ38378651-E218F559-E5ED-4DD6-A41B-997D41A0BCC8Q38652096-F609E847-9C40-4A22-BC91-97B11BED37E6Q38678186-30139F8E-884A-4C23-8B9B-B5929C327DBFQ38841187-CBDFADBB-EBEA-408F-A5C8-C2A7BF5A6105Q39469584-12F35729-6F43-4FC8-9D6D-181690EC5CE8Q39647688-145B4A05-EDA3-426C-8779-655E523C148EQ41893543-F859A870-5468-46CC-B6FA-BACF79577633Q41931928-AD6009DF-C7EF-4A57-8E3E-C34C1C2B6B79Q43461648-50E9F08B-90B1-4E2C-A0FB-49137958D143Q44480024-B491EB94-EB6D-48ED-B949-982676967D7AQ46259884-E2633CDE-B2EC-4C17-8DC7-E4189399ACADQ46281240-84F14CE3-18E4-4C92-B6AC-A7599DF06E05Q47201542-A78D635C-AB9F-46FE-B98F-A6F47ECC7C29Q47216791-8CE8AF7C-D159-45FB-A9FA-6D136B6D063BQ47233598-8528816C-F185-4998-A4B2-695F73548504Q48021054-6E9757A3-6044-42C6-81B7-E668E9881D35Q48127392-5707CDB9-2565-4610-BDED-42CE5DFEFF01Q50034109-F7BEDEF6-EC80-4F11-BD7D-726F5D4992EEQ50890208-72EC2D7A-3F76-40E4-B6BD-CA5040786D41Q51082109-B4A07D60-FB7C-46C2-B3D2-E99B79AC31B7Q51151277-EB1FCECD-9B54-4D99-8CE5-37F99BABBFFAQ51564381-8DA2CB6F-C59E-4453-82DF-6537C5227C8DQ51611738-FFD9850C-5E4E-47AD-BAA6-601BBDEA7AF9Q51724235-6915337E-8C5C-49C2-9BF5-30A7FA0FB36EQ54294286-08F72701-AE2A-4D01-86D0-3199D9CFB894Q57092005-5D0D40C0-21E3-4BC6-A2DB-2EB3E4A8FC77Q57382049-FEDBA871-2B83-406D-BEF7-4E99E5D319EE
P2860
Interactions of formulation excipients with proteins in solution and in the dried state.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Interactions of formulation excipients with proteins in solution and in the dried state.
@ast
Interactions of formulation excipients with proteins in solution and in the dried state.
@en
type
label
Interactions of formulation excipients with proteins in solution and in the dried state.
@ast
Interactions of formulation excipients with proteins in solution and in the dried state.
@en
prefLabel
Interactions of formulation excipients with proteins in solution and in the dried state.
@ast
Interactions of formulation excipients with proteins in solution and in the dried state.
@en
P1476
Interactions of formulation excipients with proteins in solution and in the dried state.
@en
P2093
Satoshi Ohtake
Yoshiko Kita
P304
P356
10.1016/J.ADDR.2011.06.011
P407
P577
2011-07-01T00:00:00Z